With new guidelines released by the U.S. Food and Drug Administration (FDA), blood donor eligibility now will be based on individuals’ responses to screening questions — rather than group-wide ...
This article is authored by Dr Joy John Mammen, professor, Department of Transfusion Medicine and Immunohaematology, ...